LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein Y72F mutatio
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutatio
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain and, additionally, carrying a glycoprotein V71S mutati
LCMV Clone 13 expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
LCMV Armstrong expressing the glycoprotein of strain WE and carrying a mutation N63K to convert the GP61-80 CD4 epitope to the sequence of the Armstrong/Clone strain
Rabbit polyclonal antiserum raised against BPL inactivated West Caucasian bat lyssavirus. The antiserum has been shown to specifically neutralize West Caucasian bat lyssavirus.
Training in Coronavirus reverse genetics to adapt novel techniques (ISA method) to large RNA viruses and compare different technologies under BSL-3 conditions
Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp (IP2/IP4) gene, for 100 Rxns (Target designed by Institut Pasteur: https://www.who.int/docs/default-source/coronaviruse/real-time-rt-pcr-assays-for-the-detection-of-sars-cov-2-institut-pasteur-paris.pdf?sfvrsn=3662fcb6_2)
The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf.
For RUO (Research Use Only)
Expression plasmids for the production of flaviviruses NS5 full length (MTase and RdRp domains). Synthetic gene optimized for E. coli. Coding sequence fused at its 5' with a cleavage 6His tag coding sequence
The in vitro transcribed RNA is the control for the first-line screening assay termed E gene assay. The SARS-CoV full virus RNA is required to control the two confirmatory assays. Dislaimer: Import permit maybe be needed in your country for the SARS-CoV full virus RNA. If yes, please indicate so in your online enquiry.
Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the RdRp gene, for 25 Rxns (Target designed by Charité Universitätsmedizin Berlin).
The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf.
For RUO (Research Use Only)
Lyophilized encapsidated RNA for SARS-CoV-2 (2019-nCoV) real time RT-PCR targeting region of the E gene, for 100 Rxns (Target designed by Charité Universitätsmedizin Berlin ; https://www.who.int/docs/default-source/coronaviruse/wuhan-virus-assay-v1991527e5122341d99287a1b17c111902.pdf).
The encapsidated RNA has been stabilized to serve as positive control for extraction and real time RT-PCR. Extraction is mandatory before use in real time RT-PCR. SOPs in the attached pdf.
For RUO (Research Use Only)
IF-slides to detect anti-nCoV antibodies by Immunofluorescence assay. The slides were prepared by infecting Vero cells with the first Swedish SARS-CoV-2 isolate (SARS-CoV-2/01/human/2020/SWE). The virus is fully sequenced (Genebank accession: MT093571). The slides are fixated in acetone, air-dried and preserved at -80°C. IF-analysis tested positive with SARS-CoV-2 infected human sera.